期刊文献+

^(201)Tl和^(99)mTc-MIBI显像定量分析在骨肉瘤新辅助化疗中的价值 被引量:1

^(201)Tl and ^(99)mTc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma
下载PDF
导出
摘要 目的:探讨201Tl和99mTc-MIBI显像在术前新辅助化疗治疗骨肉瘤中的临床价值。方法:22例在新辅助化疗前和3周期化疗后均进行201Tl显像和99mTc-MIBI显像的患者,根据肿瘤坏死率的分级[1]将其分为3组:无反应组4例(Ⅰ级<50%),部分反应组12例(Ⅱ级50%~89%),反应良好组6例(Ⅲ级>90%)。对所采集的图像数据进行定性和半定量分析,通过测量肿瘤病灶与正常组织的放射性计数,计算摄取比率(uptake ratio,UR)和变化率(alteration ratio,AR)。并采用SPSS 13.0软件进行数据分析。结果:201Tl显像时,无反应组URpre和URpost分别为2.14±0.67和2.07±0.71,两者无统计学意义(P>0.05);部分反应组URpre为3.45±1.57,URpost为2.02±0.97,两者有显著统计学意义(P<0.01);反应良好组URpre为3.57±0.67,URpost为1.36±0.20,两者有显著统计学意义(P<0.01);99mTc-MIBI显像时,无反应组URpre为1.66±0.42,URpost为1.85±0.70,两者无统计学意义(P>0.05);部分反应组URpre为2.39±1.41,URpost为1.68±0.72,两者有统计学意义(P<0.05);反应良好组URpre为2.56±0.60,URpost为1.19±0.14,两者有显著统计学意义(P<0.01);201Tl显像时AR值范围为-0.03~0.72,AR值和TNR之间存在良好的相关性,相关系数r=0.95;99mTc-MIBI显像时AR值范围为-1.21~0.64,AR值和TNR之间存在良好的相关性,相关系数r=0.71;201Tl显像的AR值与99mTc-MIBI显像的AR值之间存在良好的相关性,相关系数r=0.70。结论:201Tl显像与99mTc-MIBI显像显示新辅助化疗后AR值与TNR均存在良好的相关性,对骨肉瘤化疗疗效的评估有重要意义。201Tl显像对骨肉瘤化疗疗效的评估优于99mTc-MIBI显像,但两者无显著差别。 Objective: To evaluate the application of 201Tl and 99mTc-MIBI scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma.Methods: Twenty-two patients with osteosarcoma underwent both 201Tl and 99mTc-MIBI scintigraphy.According to tumor necrosis rate(TNR),22 patients were classified into three groups:Group 1(necrosis less than 50%),Group 2(50%~89% necrosis) and Group 3(necrosis greater than 90%).The uptake ratio(UR) was obtained in images before and after chemotherapy.The alteration ratio(AR) and tumor necrosis ratio(TNR) were calculated.Results: In 201Tl images,URpre and URpost(mean±s.d.) of Group 1 were 2.14±0.67,2.07±0.71(P0.05);URpre and URpost of Group 2 were 3.45±1.57 and 2.02±0.97(P0.01);URpre and URpost of Group 3 were 3.57±0.67 and 1.36±0.20(P0.01).In 99mTc-MIBI images,URpre and URpost of Group 1 were 1.66±0.42 and 1.85±0.70(P0.05);URpre and URpost of Group 2 were 2.39±1.41 and 1.68±0.72(P0.05);URpre and URpost of Group 3 were 2.56±0.60 and 1.19±0.14(P0.01).The AR value in 201Tl scintigraphy was-0.03-0.72,the liner regression analysis of AR versus TNR showed a highly significant positive correlation(r=0.95).The AR value in 99mTc-MIBI scintigraphy was-1.21-0.64,the liner regression analysis of AR versus TNR showed a highly significant positive correlation(r=0.71).The liner regression analysis of AR in 201Tl scintigraphy versus AR in 99mTc-MIBI scintigraphy showed a highly significant positive correlation(r=0.70).Conclusion: The AR changes significantly after neoadjuvant chemotherapy and is positively correlated with TNR,which indicates that 201TI-and 99mTc-MIBI scintigraphy can be used for evaluation of neoadjuvant chemotherapy.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期183-187,191,共6页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省卫生厅科研项目(2010KYB060) 浙江省教育厅科研项目(Y200906607)
关键词 铊放射性同位素/诊断应用 99m锝甲氧基异丁基异腈/诊断应用 骨肿瘤/药物疗法 化学疗法 辅助 抗肿瘤药/治疗应用 201铊/诊断应用 99m锝甲氧基异丁基异腈/诊断应用 骨肉瘤/放射性核素显像 化疗 相关性 Thallium radioisotopes/diag use Technetium Tc 99m sestamibi/diag use Bone neoplasms/drug ther Chemotherapy adjuvant Antineoplastic agents/ther use Thallium-201/diag use 99mTc-MIBI/diag use Osteosarcoma/radionuclide Chemo-therapy Relationship
  • 相关文献

参考文献2

二级参考文献11

  • 1魏玲,宋现让,王兴武,李敏,左文述.MDR1和GST-π在骨软组织肉瘤中的表达及其与化疗耐药的关系[J].中华肿瘤杂志,2006,28(6):445-448. 被引量:15
  • 2Sugawara Y,Kikuchi T,Kajihara M,et al. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans. Ann Nucl Med, 2005, 19:461-468.
  • 3Menedez LR, Fideler BM, Mira J. Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma. J Bone Joint Surg Am, 1993, 75:526-531.
  • 4Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant ehemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer, 1982, 49 : 1221-1230.
  • 5Nishiyama Y, Yamamoto Y, Yokoe K, et al. A comparative study of 201 Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors. Ann Nucl Med, 2004, 18:235-241.
  • 6Kostakoglu L,Panicek DM,Divgi CR, et al. Con'elation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med, 1995, 22:1232-1237.
  • 7Moon SH, Shin KH, Suh JS, et al. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma. Yonsei Med J, 2005, 46 : 119-124.
  • 8Lale Kostakoglu,David M. Panicek,Chaitanya R. Divgi,Jose Botet,John Healy,Steven M. Larson,Hussein M. Abdel-Dayem. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas[J] 1995,European Journal of Nuclear Medicine(11):1232~1237
  • 9杨迪生,范顺武,陶惠民,叶招明,何荣新.骨肉瘤辅助化疗方案的中、远期疗效观察[J].中华骨科杂志,2000,20(1):35-39. 被引量:27
  • 10范顺武,严世贵,杨迪生,叶招明,陶惠民,李伟栩,方向前.保肢术结合辅助化疗治疗肢体ⅡB期骨肉瘤[J].中华骨科杂志,2000,20(7):393-399. 被引量:18

共引文献2

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部